Literature DB >> 16797221

Functional and immunological insights from the three-dimensional structures of Plasmodium surface proteins.

Graham A Bentley1.   

Abstract

Malaria is a major global health problem and is caused by the unicellular parasite Plasmodium. Plasmodial surface proteins have important roles in host cell invasion and are responsible for antigenic diversity in this organism. Knowledge of the three-dimensional structure of surface proteins can facilitate our understanding their biological function, and contribute to the development of therapeutic and vaccine strategies against malaria. Structural studies allow rational drug design when ligand- or receptor-binding sites are identified and characterized. Analysis of the three-dimensional distribution of protective antibody epitopes and polymorphic residues can facilitate vaccine candidate optimization. With this in mind, some Plasmodium surface-protein structures have determined by X-ray crystallography or nuclear magnetic resonance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797221     DOI: 10.1016/j.mib.2006.06.002

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  3 in total

1.  A hybrid multistage protein vaccine induces protective immunity against murine malaria.

Authors:  Balwan Singh; Monica Cabrera-Mora; Jianlin Jiang; Alberto Moreno
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

2.  Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate.

Authors:  Balwan Singh; Monica Cabrera-Mora; Jianlin Jiang; Mary Galinski; Alberto Moreno
Journal:  Vaccine       Date:  2010-01-22       Impact factor: 3.641

3.  New insights for native production of MSP1(19), the disulfide-rich C-terminal fragment from Plasmodium falciparum merozoite surface protein 1.

Authors:  Anne-Gaëlle Planson; J Iñaki Guijarro; Alain F Chaffotte
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.